SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-18-037317
Filing Date
2018-06-12
Accepted
2018-06-12 18:52:00
Documents
1
Period of Report
2018-05-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4200
  Complete submission text file 0001209191-18-037317.txt   5764
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Issuer) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CALITHERA BIOSCIENCES 343 OYSTER POINT BLVD, SUITE 200 SO. SAN FRANCISCO CA 94080
Business Address
Waddill William D. (Reporting) CIK: 0001553338 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37852 | Film No.: 18895559